This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .

Kenvue stock has recently experienced a shift in analyst sentiment, leading to a reduction in the consensus price target from ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

The Texas-based Kimberly-Clark Corporation announced Monday it reached a deal to purchase Kenvue for $48.7 billion.

Desjardins initiates buy ratings on Constellation Software, Topicus.com and Lumine Group, citing long-term growth and ...